Hongming Chen

President and Head of Research & Development @ METiS Therapeutics

Known information

Holds a Sc.D. degree

About METiS Therapeutics

METiS Therapeutics, launched with $86 million in Series A financing, focuses on using AI and machine learning to revolutionize drug discovery and delivery, targeting small molecules, biologics, and nucleic acids.

Report inaccurate information

People similar to Hongming Chen

Jian Irish

President & COO @ Metagenomi

Jian Irish is the President and COO, holding both a PhD and an MBA.

Narbe Mardirossian

Chief Technology Officer @ Terray Therapeutics

Elliot Ehrich

CMO and EVP, Translational Science @ LifeMine Therapeutics

Elliot Ehrich is the CMO and EVP of Translational Science with over 25 years of experience in pharma and biotech, having contributed to the development and registration of 8 medicines across various therapeutic areas.